Related Experiment Videos
Ophthalmology's botanical heritage
1School of Medicine, University of California, Davis.
Survey of Ophthalmology
|March 1, 1992
Summary
Many ophthalmic drugs originate from ethnobotanical sources, like Solanaceous plants providing atropine. Understanding this history reveals valuable compounds, but rainforest loss threatens future discoveries.
Area of Science:
- Ethnobotany
- Ophthalmology
- Pharmacology
Background:
- Ophthalmic pharmaceuticals often have deep ethnobotanical roots.
- Historical use of plants like Solanaceous species (atropine source) in Western medicine.
- Traditional applications of physostigmine and pilocarpine-containing plants in West African and Amazonian cultures.
Observation:
- Folkloric reputations of plants led 19th-century scientists to investigate their medicinal properties.
- Discovery of active compounds and documentation of physiological effects from these botanical sources.
- Key ophthalmologists utilized this research for therapeutic applications.
Findings:
- Established ophthalmic drugs like atropine, physostigmine, and pilocarpine are derived from specific plant families.
- Scientific validation confirmed the efficacy of compounds used traditionally for centuries.
- Historical research paved the way for modern ophthalmological treatments.
Implications:
- The loss of tropical rainforests poses a significant threat to undiscovered medicinal compounds.
- Urgent need for biodiversity conservation to preserve potential future pharmaceutical resources.
- Highlighting the importance of ethnobotanical research in drug discovery.